109 related articles for article (PubMed ID: 10214370)
1. [Psychosocial aspects of predictive gene diagnosis in familial breast and ovarian carcinomas].
von der Groeben C; Neef K; Rohde A; Bodden-Heidrich R; Schmutzler RK
Dtsch Med Wochenschr; 1999 Mar; 124(12):361-2. PubMed ID: 10214370
[No Abstract] [Full Text] [Related]
2. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial aspects of familial breast and ovarian cancer: psychological guidelines for genetic testing.
Decruyenaere M; Evers-Kiebooms G; Claes E; Denayer L; Welkenhuysen M; Legius E; Demyttenaere K
Dis Markers; 1999 Oct; 15(1-3):152-3. PubMed ID: 10595271
[No Abstract] [Full Text] [Related]
4. [Psychological aspects of predictive genetic diagnosis in breast and ovarian carcinoma].
Tiefensee I; Klusmann D
Psychother Psychosom Med Psychol; 1998; 48(9-10):369-74. PubMed ID: 9785966
[TBL] [Abstract][Full Text] [Related]
5. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
Struewing JP; Lerman C; Kase RG; Giambarresi TR; Tucker MA
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):169-73. PubMed ID: 7742725
[TBL] [Abstract][Full Text] [Related]
6. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
7. Popularity of breast cancer program leads to referral protocols in BC.
Kent H
CMAJ; 1998 Oct; 159(7):832-3. PubMed ID: 9805033
[TBL] [Abstract][Full Text] [Related]
8. [Hereditary breast and ovarian cancer syndrome].
Plevová P; Novotný J; Petráková K; Palácová M; Kalábová R; Schneiderová M; Foretová L
Klin Onkol; 2009; 22 Suppl():S8-11. PubMed ID: 19764385
[No Abstract] [Full Text] [Related]
9. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
[TBL] [Abstract][Full Text] [Related]
10. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
Olopade OI
Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
[No Abstract] [Full Text] [Related]
11. Genetic testing for breast and ovarian cancer risk: the psychosocial issues.
Pasacreta JV; Jacobs L; Cataldo JK
Am J Nurs; 2002 Dec; 102(12):40-7; quiz 48. PubMed ID: 12473929
[No Abstract] [Full Text] [Related]
12. [Possibilities of examination of familial breast cancers and ovarian cancers. Use of molecular-genetic analysis of the BRCA1 gene and the BRCA2 gene].
Backe J; Mulfinger L
Krankenpfl J; 1996 Oct; 34(10):440-5. PubMed ID: 8949022
[No Abstract] [Full Text] [Related]
13. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
Khabele D; Runowicz CD
Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
[TBL] [Abstract][Full Text] [Related]
14. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
[TBL] [Abstract][Full Text] [Related]
15. Genetic/familial high-risk assessment: breast and ovarian.
Daly MB; Axilbund JE; Bryant E; Buys S; Eng C; Friedman S; Esserman LJ; Farrell CD; Ford JM; Garber JE; Jeter JM; Kohlmann W; Lynch PM; Marcom PK; Nabell LM; Offit K; Osarogiagbon RU; Pasche B; Reiser G; Sutphen R; Weitzel JN;
J Natl Compr Canc Netw; 2006 Feb; 4(2):156-76. PubMed ID: 16451772
[No Abstract] [Full Text] [Related]
16. Clinical implications of genetic testing for inherited breast and ovarian cancer risk.
Calzone KA
Nurs Spectr (Wash D C); 1998 Nov; 8(23):12-4. PubMed ID: 10542772
[No Abstract] [Full Text] [Related]
17. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
18. Breast & ovarian cancer. Issues in risk assessment.
Caro SW
Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
[No Abstract] [Full Text] [Related]
19. Genetic testings for cancer: the surgeon's critical role. Familial breast cancer.
Weber BL
J Am Coll Surg; 1999 Jan; 188(1):79-86. PubMed ID: 9915248
[No Abstract] [Full Text] [Related]
20. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
